Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Tadalafil: a new treatment option for men with erectile dysfunction

May 14, 2002

Tadalafil, an important new treatment option for most men with ED

May 13, 2002

Alpha1-adrenoceptor antagonists useful for urological disorders

May 10, 2002

YC-1 may be useful for treating erectile dysfunction

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

Uroselective alpha1-adrenoceptor blockers designed at Recordati

May 9, 2002

Possible beneficial effects of GABA uptake inhibition on micturition

May 9, 2002

CTGF as a therapeutic target in the prevention of nephropathy following kidney transplantation

May 6, 2002

Shire submits NDA for Foznol

May 2, 2002

Vasomax MAA to be withdrawn in U.K.

May 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...